ICD10 code of Vestibular Schwannoma and ICD9 code

The primary ICD-10-CM code for a vestibular schwannoma (often referred to as an acoustic neuroma) is D33.3, which classifies benign neoplasms of the cranial nerves. In the older ICD-9-CM classification system, this condition was coded as 225.1, representing a benign neoplasm of the cranial nerves.

What is a vestibular schwannoma?

A vestibular schwannoma is a slow-growing, benign (non-cancerous) tumor that develops on the vestibular nerve, which leads from the inner ear to the brain. Because it arises from the Schwann cells that wrap around the nerve, it can cause significant pressure on the auditory and vestibular systems. While vestibular schwannoma is not malignant, its proximity to critical brainstem structures means that its growth can lead to hearing loss, tinnitus, and balance disturbances. At DiseaseMaps.org, we have seen 525 community members share their personal journeys with vestibular schwannoma, highlighting the diverse ways this diagnosis impacts daily life.

How is a vestibular schwannoma diagnosed?

Diagnosis of a vestibular schwannoma typically involves a combination of clinical evaluation and advanced imaging. Because symptoms like hearing loss can be subtle or mimic other conditions, physicians often order an MRI with gadolinium contrast, which is the gold standard for identifying these tumors. Audiometric testing is also essential to assess the degree of nerve function impairment. Common clinical indicators that prompt further investigation include:

• Unilateral (one-sided) sensorineural hearing loss


• Persistent, high-pitched tinnitus


• Unexplained episodes of vertigo or imbalance


• A sensation of fullness or pressure in the affected ear

Is a vestibular schwannoma hereditary?

The vast majority of cases occur sporadically, meaning they are not passed down through families. However, bilateral vestibular schwannoma—where tumors occur on both sides—is a hallmark clinical feature of Neurofibromatosis Type 2 (NF2). NF2 is a rare genetic disorder caused by a mutation in the NF2 gene on chromosome 22. For individuals diagnosed with bilateral tumors, a referral to a clinical geneticist is vital to assess the risk of transmission to offspring and to discuss comprehensive management strategies for the condition.

What are the management options?

Management strategies for a vestibular schwannoma are highly individualized, depending on the tumor size, the patient's age, and their current hearing status. The "wait and scan" approach, or observation with serial MRIs, is often recommended for smaller, asymptomatic tumors. For growing tumors, treatment options include microsurgical resection or stereotactic radiosurgery (such as Gamma Knife). It is important to consult with a multidisciplinary team, including a neurotologist and a neurosurgeon, to weigh the risks and benefits of each intervention.

Next steps

• Consult with a neurotologist or neurosurgeon who specializes in skull base tumors to discuss your specific imaging results.


• Request a formal hearing evaluation from an audiologist to establish a baseline for your auditory nerve function.


• Join the vestibular schwannoma support community at DiseaseMaps.org to connect with others who have navigated similar treatment decisions.


• If you have bilateral tumors, schedule a consultation with a genetic counselor to discuss NF2 testing.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified physician regarding any medical condition.

References

• NIH GARD (Genetic and Rare Diseases Information Center): Vestibular schwannoma overview and clinical characteristics.


• Orphanet: Classification and clinical management guidelines for acoustic neuroma (ORPHA:96078).


• OMIM (Online Mendelian Inheritance in Man): Genetic information regarding NF2 and associated vestibular schwannoma (#101000).


• Acoustic Neuroma Association: Patient-centered resources and clinical management data.